Hematology and Oncology Associates-Oakland
About Hematology and Oncology Associates-Oakland
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
38
Alliance for Clinical Trials in Oncology
7
SWOG Cancer Research Network
6
Celgene
1
Clovis Oncology, Inc.
1
Diamyd Inc
1
ECOG-ACRIN Cancer Research Group
1
ETOP IBCSG Partners Foundation
1
Precision Therapeutics
1
Clinical Trials at Hematology and Oncology Associates-Oakland
During the past decade, Hematology and Oncology Associates-Oakland conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 32 clinical trials were completed, i.e. on
average, 3200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer
2005-08-15
2017-11-28
Completed
188
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2005-09-01
2015-04-01
Completed
1,873
Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
2006-02-09
2011-03-15
Completed
118
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
2006-04-24
2021-09-01
Completed
1,943
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hematology and Oncology Associates-Oakland" #1 sponsor was "National Cancer Institute (NCI)" with 38 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials
sponsored, "SWOG Cancer Research Network" with 6 trials sponsored, "Celgene" with 1 trials sponsored and "Clovis Oncology, Inc."
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology and Oncology Associates-Oakland"
#1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 12 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at Hematology and Oncology Associates-Oakland
According to Clinical.Site data, the most researched conditions in "Hematology and Oncology Associates-Oakland" are
"Recurrent Breast Carcinoma" (8 trials), "Stage IIIB Breast Cancer AJCC v7" (6 trials), "Stage IIIC Breast Cancer AJCC v7" (6 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (5 trials) and "Stage IIB Breast Cancer AJCC v6 and v7" (5 trials). Many other conditions were trialed in "Hematology and Oncology Associates-Oakland" in a lesser frequency.
Clinical Trials Intervention Types at Hematology and Oncology Associates-Oakland
Most popular intervention types in "Hematology and Oncology Associates-Oakland" are "Drug" (50 trials), "Other" (40 trials), "Biological" (24 trials), "Radiation" (10 trials) and "Procedure" (9 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (30 trials), "Bevacizumab" (15 trials), "Quality-of-Life Assessment" (13 trials), "Paclitaxel" (12 trials) and "Carboplatin" (11 trials). Other intervention names were less common.
Clinical Trials Genders at Hematology and Oncology Associates-Oakland
The vast majority of trials in "Hematology and Oncology Associates-Oakland" are
42 trials for "All" genders and 15 trials for "Female" genders.
Clinical Trials Status at Hematology and Oncology Associates-Oakland
Currently, there are NaN active trials in "Hematology and Oncology Associates-Oakland".
undefined are not yet recruiting,
3 are recruiting,
28 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 23 completed trials in Hematology and Oncology Associates-Oakland,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Hematology and Oncology Associates-Oakland, 2 "Phase 1"
clinical trials were conducted, 16 "Phase 2" clinical
trials and 37 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".